Here is this week’s Deal Report for private equity and venture capital activity for US-based PE and VC firms and portfolio companies, brought to you by Scherzer International and Lucas and Associates, LLC.
PE and VC Firms
$85M
Debut special situations and credit fund focused on biomedical tech companies.
$450M
Second opportunistic private credit fund
$322M
Debut fund ($216M) and a co-investment fund ($106M)
$332M
Third fund
Private Equity Deals
GHO Capital and Vistria Group
Undisclosed
Wilmington, NC-based biotech contract development and manufacturing organization
Arsenal Capital Partners
$449M
Princeton, NJ-based maker of drug development biosimulation software
Astara Capital Partners
Undisclosed
Sanford, FL-based provider of residential HVAC, plumbing, and other home services
Francisco Partners
Undisclosed
San Francisco, CA-based maker of PC gaming hardware
Genstar Capital
Undisclosed
Southlake, TX-based mobile device protection company
Northleaf Capital Partners
Undisclosed
Topeka, KS-based provider of broadband services to select Midwestern rural markets
North Castle Partners
Undisclosed
New York, NY-based fragrance brand
5th Century Partners
$20M
San Francisco, CA-based maker of acne treatment products
Allied Industrial Partners
Undisclosed
Raleigh, NC-based solid waste management company
TSG Consumer Partners and Oak Hill Capital
Undisclosed
Marietta, GA-based provider of residential HVAC, plumbing, and electrical services
Venture Capital Deals
Keurig Dr. Pepper, TRB Advisors, Alliance Consumer Growth
$50M
Stratford, CT-based nonalcoholic beer brewer
Riverwood Capital
$40M
Miami, FL-based auto customer data and experience platform
Nava Ventures, Accel
$15M
San Francisco, CA-based cloud database startup
Sageview Capital and Omega Venture Partners co-led and were joined by Gutbrain Ventures and Digitalis Ventures
$41M
Cambridge, MA-based developer of a lab intelligence platform
Tracker Capital, Celestra, Intel, Micron
$40M
Santa Clara, the CA-based manufacturer of semiconductors, interconnects to accelerate chiplet-based systems.
Lightspeed Venture Partners, Alkeon Capital, Cedars-Sinai, Inflect Health, ApolloMD, Founders Fund, Tarsadia
$46M
San Francisco, CA-based automated medical coding startup
Lightspeed Venture Partners, Alameda Research, Jump Capital, Castle Island
$18M
New York, NY-based institutional DeFi wallet maker
Cota Capital, AV8 Ventures, Markd, Startup Venture Capital, Maiden Re
$22.5M
San Franciso, CA-based digital insurer for small businesses
Riverstone Holdings Latin America, Alliance Resource Partners, Caterpillar Venture Capital, Cottonwood Technology Fund
$30M
Round Rock, TX-based developer of air core motors
Mubadala Capital, Horizons Ventures, Bison Ventures, Manta Ray Ventures, Irongrey, Alumni Ventures, Plum Alley, Transform VC, BoxOne Ventures, Intersect VC, Compound, Felicis
$41M
Redwood City, CA-based computational platform for mapping the therapeutic potential of secreted proteins
Fin Capital, Centana Growth Partners, JPMorgan Growth Equity Partners, Canapi Equity Partners, ThirdPrime
$50M
New York, NY-based security compliance platform
Akamai Technologies, Shasta Ventures, 60 Degree Capital
$38M
San Mateo, CA-based edge cloud computing startup
Primus Capital Partners
$100M
New York, NY-based provider of subscription solutions for retailers and DTC brands
Santé Ventures, Route 66 Ventures, CU Healthcare Innovation Fund, WPSS.bio, Palo Santo, Iter Investments, Ocama Partners, re.Mind Capital
$30M
Boston, MA-based developer of psychoactive medicines for mental health
Thoma Bravo, Goldman Sachs, PayPal Ventures, Amex Ventures, Citi Ventures
$70M
San Francisco, CA-based blockchain intelligence startup
3L Capital, Origin Ventures, Chapford Capital Group, Plus Capital, Lily Collins, Nina Dobrev
$35M
New York, NY-based rental service for designer handbags, jewelry, and diamonds
Enavate Sciences, Longitude Capital, Vivo Capital, Rock Springs Capital, Perceptive Advisors, Agent Capital, Pivotal bioVenture Partners, Superstring Capital, Fairmount, Wellington Management, Tellus BioVentures, Quan Venture Fund, Xencor
$118M
Waltham, MA-based developer of therapeutics for autoimmune disaese